Drug Eluting Stents

This October, we take a closer look at a component that redefined vascular intervention: the drug-eluting stent.

At first glance, it’s a familiar geometry: a metallic scaffold designed to reopen a blocked artery and hold it open. But it’s the outer layer that changed everything. The coating turns the stent into a controlled delivery system, releasing active agents exactly where they’re needed. The design space is wide. Different drugs, different elution profiles. Some coatings release fast, others are staged in layers or gradients. In bioresorbable systems, the formulation can even control how quickly the stent itself degrades.

These details influence more than just pharmacokinetics. They affect fatigue behavior, radial strength and how the stent integrates with the vessel wall over time.

At MeKo, we support these challenges with an open mind and decades of experience. If you’re curious about our DES solutions, tune in tomorrow or Thursday for our Webinar on Polymer Coating at www.meko.de/webinars.

Can’t make it live? A full recording will be available afterward.